SCOLR hits “milestone”
This article was originally published in The Tan Sheet
Executive Summary
Bellevue, Wash.-based firm SCOLR Pharma announces Sept. 26 that it has achieved a "milestone" in its development and license agreement with Wyeth Consumer Healthcare, which will result in a payment from Wyeth. SCOLR expects to report the payment as "research and development revenues" for the quarter ended Sept. 30. In the original December 2005 agreement, SCOLR granted Wyeth the worldwide rights to utilize SCOLR's patented Controlled Delivery Technology for potential use in an OTC formulations, according to the firm...